This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

S. Douglas Frasier
Chief of Pediatrics Olive View Medical Center 14445 Olive View Dr Sylmar,Sylmar,91342-1495

Am J Dis Child. 1987;141(6):604-605.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—Dr Lee's first point cannot be answered directly, since the population served by the Los Angeles County/USC Medical Center pediatric Diabetic Clinic is 90% to 95% Hispanic. There were not enough white or black patients to provide an internal comparison of the prevalence of AMAs, and we were forced to rely on data in the literature for this purpose.

The main questions raised by Dr Lee concern the process of laboratory screening for thyroid dysfunction, the clinical evaluation of thyroid function in patients with diabetes, and the indications for treatment in this population. We recommended screening for thyroid autoimmunity with laboratory assessment of thyroid funtion in those patients who are found to have circulating AMAs. This approach first asks a pathogenetic question and reserves laboratory assessment of thyroid function for those patients found to have a marker of thyroid autoimmunity. As Dr Lee indicates, the assessment of autoimmunity must . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?